Study on the Correlation Between Blood Concentration of Sintilimab and Related Predictors with Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer
Latest Information Update: 29 Nov 2024
Price :
$35 *
At a glance
- Drugs Sintilimab (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Pharmacokinetics
- 29 Nov 2024 New trial record